Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity
Avatar

Prospects of Targeted Therapy for Adverse Events: TNF, IL6, and T Cell Differentiation Therapies

By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Leonard Calabrese
By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Leonard Calabrese
252 views
March 24, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh
It Isn’t Just Joint Pain
21:50

Adverse Events - Immunobiology of CPIs and Autoimmunity: PD-1 Pathwa…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

L. Calabrese

41 views
16:28

Immunologic Basis of Adverse Events: Does Immunosuppression Used for…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

L. Calabrese

334 views
09:52

Prospects of Targeted Therapy for Adverse Events: TNF, IL6, and T Ce…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

L. Calabrese

252 views
19:05

Rheumatic Immune Related Adverse Events from CPIs: Current and New T…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

C. Calabrese

18 views
18:50

62 y/o Male With Stage IV Renal Cell Carcinoma: Managing Rheumatic I…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

E. Kirchner, C. Calabrese, L. Calabrese

25 views